Garrick C. Stewart

Garrick C. Stewart

Auto-generated profile, based on publicly available information

Garrick C. Stewart

Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women’s Hospital , Boston, MA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2021 in Cardiac Failure Review
Verified
Journal Article
Open access
PDF file
GGGerard T Giblin
Gerard T Giblin
LMLaura Murphy
Laura Murphy
GSGarrick C Stewart
Garrick C Stewart
ADAkshay S Desai
Akshay S Desai
MCMarcelo F Di Carli
Marcelo F Di Carli
NLNeal K Lakdawala
Neal K Lakdawala
Sarcoidosis is a complex, multisystem inflammatory disease with a heterogeneous clinical spectrum. Approximately 25% of patients with systemic sarcoidosis will have cardiac involvement that portends a poorer outcome. The diagnosis, particularly of isolated cardiac sarcoidosis, can be challenging. A paucity of randomised data exist on who, when and how to treat myocardial inflammation in cardiac sarcoidosis. Despite this, corticosteroids continue to be the mainstay of therapy for the inflammatory phase, with an evolving role for steroid-sparing and biological agents. This review explores the immunopathogenesis of inflammation in sarcoidosis, current evidence-based treatment indications and commonly used immunosuppression agents. It explores a multidisciplinary treatment and monitoring approach to myocardial inflammation and outlines current gaps in our understanding of this condition, emerging research and future directions in this field.

1 April 2017 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
PDF file
MPM. Palardy
M. Palardy
RMR. McLean
R. McLean
SPS. Pamboukian
S. Pamboukian
MKMichelle M. Kittleson
Michelle M. Kittleson
LSL. Warner Stevenson
L. Warner Stevenson
FIF. REVIVAL Investigators
F. REVIVAL Investigators

1 December 2015 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
EJEmer Joyce
Emer Joyce
GSGarrick C. Stewart
Garrick C. Stewart
MHMaryclare Hickey
Maryclare Hickey
LCLara Coakley
Lara Coakley
JRJose M. Rivero
Jose M. Rivero
MMMandeep Mehra
Mandeep Mehra

1 March 2017 in Vascular Health and Risk Management
Verified
Journal Article
Open access
PDF file
SCSunit-Preet Chaudhry
Sunit-Preet Chaudhry
GSGarrick C Stewart
Garrick C Stewart
Heart failure is a complex clinical syndrome resulting from impairment of ventricular filling or ejection of blood associated with symptoms of dyspnea, fatigue, as well as peripheral and/or pulmonary edema. This syndrome is progressive and characterized by worsening quality of life despite escalating levels of care, affecting 5.7 million Americans with an annual cost of over $30 billion US dollars. Treatment for this syndrome has evolved over three distinct eras: the nonpharmacological era, the pharmacological era, and the device era, with the focus shifting from symptomatic relief to decreasing morbidity and mortality. Over the past 10 years, the field has undergone a renaissance, with the development of new pharmacologic, hemodynamic monitoring, and device therapies proven to improve outcomes in patients with heart failure. This article will review several recent innovations in the management of patients with heart failure.

3 April 2020 in Artificial Organs
Verified
Journal Article
Closed access
PDF file
JRJose B. Cruz Rodriguez
Jose B. Cruz Rodriguez
GSGarrick C. Stewart
Garrick C. Stewart
SPSalpy V. Pamboukian
Salpy V. Pamboukian
JTJose A. Tallaj
Jose A. Tallaj
IRIndranee Rajapreyar
Indranee Rajapreyar
DADeepak Acharya
Deepak Acharya

1 April 2016 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Open access
MKM. Kim
M. Kim
MMMandeep Mehra
Mandeep Mehra
GSG.C. Stewart
G.C. Stewart
GCG.S. Couper
G.S. Couper
DPD.S. Page
D.S. Page
MGM.M. Givertz
M.M. Givertz